Showing results (241-250 of 481) with videos related to
Sort By:
Pageof 49
The Journal of Clinical Endocrinology and Metabolism|August 12, 1999
Effect of testosterone treatment on body composition and muscle strength in men over 65 years of ageP J Snyder, H Peachey, P Hannoush, et al.Nature|November 4, 2016
Leukaemogenic effects of Ptpn11 activating mutations in the stem cell microenvironmentLei Dong, Wen-Mei Yu, Hong Zheng, et al.Blood|February 24, 2006
Prospective analysis of TEL/AML1-positive patients treated on Dana-Farber Cancer Institute Consortium Protocol 95-01Mignon L Loh, Meredith A Goldwasser, Lewis B Silverman, et al.The Journal of Biological Chemistry|January 11, 2018
The interplay between citrullination and HLA-DRB1 polymorphism in shaping peptide binding hierarchies in rheumatoid arthritisYi Tian Ting, Jan Petersen, Sri H Ramarathinam, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 28, 2014
Detection of minimal residual disease in B lymphoblastic leukemia by high-throughput sequencing of IGHDavid Wu, Ryan O Emerson, Anna Sherwood, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 21, 2009
Outcome of patients treated for relapsed or refractory acute lymphoblastic leukemia: a Therapeutic Advances in Childhood Leukemia Consortium studyRichard H Ko, Lingyun Ji, Phillip Barnette, et al.Biomed Research International|January 13, 2015
Risk factors for hospital and long-term mortality of critically ill elderly patients admitted to an intensive care unitA Mukhopadhyay, B C Tai, K C See, et al.Cancer Cell|October 7, 2008
Single-cell profiling identifies aberrant STAT5 activation in myeloid malignancies with specific clinical and biologic correlatesNikesh Kotecha, Nikki J Flores, Jonathan M Irish, et al.Blood|September 15, 2022
Recombinant Erwinia asparaginase (JZP458) in acute lymphoblastic leukemia: results from the phase 2/3 AALL1931 studyLuke Maese, Mignon L Loh, Mi Rim Choi, et al.Genome Biology|April 4, 2023
NSD2 E1099K drives relapse in pediatric acute lymphoblastic leukemia by disrupting 3D chromatin organizationSonali Narang, Nikki A Evensen, Jason Saliba, et al.Pageof 49